Springworks Therapeutics, Inc., A Healthcare Company Of Merck Kgaa, Darmstadt, Germany

This study tests a drug called mirdametinib in 114 adults and children with a genetic condition called NF1 that causes nerve tumors (plexiform neurofibromas) that cannot be surgically removed and cause serious problems. The goal is to see if the drug can shrink these tumors by at…

This study tests a drug called nirogacestat in 20 Japanese adults with desmoid tumors that are growing. Desmoid tumors are non-cancerous but can cause pain and disability. The goal is to see if the drug can shrink or stop the tumors. Participants take the drug by mouth and are mo…